India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The positive outcome clears the way for Glenmark to resume commercial manufacturing at the site
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
A key highlight will be Brenntag’s qualified amino acids portfolio
Millions of stroke survivors across the world may soon have a new defense
Subscribe To Our Newsletter & Stay Updated
